| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |